Stock BTTX BETTER THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Market Closed - OTC Markets
Other stock markets
 03:51:33 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.0085 USD -12.82% Intraday chart for Better Therapeutics, Inc. +4.94% -95.64%
May. 22 Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc.. CI
Mar. 21 Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc CI

Evolution of the average Target Price on Better Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d688580aa102353cb95de07d80dbe.fHGiJDzSlplxfvn6e6C7_JBoNitxR9NZkkDpSUOZUak.FSnxEnGx8epEG8yqNfX9usoncG4CL-Io6BnRIjT7CZkYReFXWIr51SMUuA~e731de97208726e31445b52295a59e61

Analyst Recommendations on Better Therapeutics, Inc.

Lake Street Adjusts Better Therapeutics' Price Target to $5 From $6, Keeps Buy Rating MT
Chardan Lowers Price Target on Better Therapeutics to $9 From $14, Reflecting Higher Projected Sharecount Dilution, Maintains Buy Rating MT
Chardan Cuts Price Target on Better Therapeutics to $14 From $17 on Higher Expected Share Count Dilution, Reiterates Buy Rating MT
Chardan Adjusts Better Therapeutics' Price Target to $17 From $15, Keeps Buy Rating MT
Chardan Raises Price Target on Better Therapeutics to $18 From $17, Maintains Buy Rating MT
LifeSci Capital Starts Better Therapeutics at Outperform With $15 Price Target MT
Chardan Starts Better Therapeutics at Buy With $17 Price Target MT
Cowen Initiates Coverage on Better Therapeutics With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0085 USD
Average target price
1.5 USD
Spread / Average Target
+17,547.06%
High Price Target
1.5 USD
Spread / Highest target
+17,547.06%
Low Price Target
1.5 USD
Spread / Lowest Target
+17,547.06%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Better Therapeutics, Inc.

Lake Street
Chardan Research
LifeSci Capital
Chardan
Cowen

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTTX Stock
  4. Consensus Better Therapeutics, Inc.